Janetta Trochimiuk
Fortune : 241 $ au 31/08/2026
Fortune : 241 $ au 31/08/2026
Janetta Trochimiuk is currently Controller at PDS Biotechnology Corp.
since 2019.
Formerly, Controller at Delcath Systems, Inc. from 2017 to 2019, Chief Financial Officer at Ceragon Networks, Inc. from 2009 to 2012, and Controller-North America at Olam Americas, Inc. from 2005 to 2007.
Education includes undergraduate degree from Baruch College.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/09/2026 | 1 124 ( 0 % ) | 241 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Comptroller/Controller/Auditor | 01/12/2019 |
| Sociétés | Poste | Fin |
|---|---|---|
| DELCATH SYSTEMS, INC. | Comptroller/Controller/Auditor | 01/07/2019 |
Ceragon Networks, Inc.
Ceragon Networks, Inc. Specialty TelecommunicationsCommunications Provides wireless backhaul and fronthaul solutions | Directeur Financier/CFO | 01/10/2012 |
Olam Americas, Inc.
Olam Americas, Inc. Agricultural Commodities/MillingProcess Industries Provides crop preparation services | Comptroller/Controller/Auditor | 01/09/2007 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Delcath Systems, Inc.
Delcath Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures drugs for treatment of cancer | Health Technology |
Baruch College
Baruch College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olam Americas, Inc.
Olam Americas, Inc. Agricultural Commodities/MillingProcess Industries Provides crop preparation services | Process Industries |
Ceragon Networks, Inc.
Ceragon Networks, Inc. Specialty TelecommunicationsCommunications Provides wireless backhaul and fronthaul solutions | Communications |
PDS Biotechnology Corp.
PDS Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Develops clinical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national